BRCA1 modulator (MCP Hahnemann Uni)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameBRCA1 modulator (MCP Hahnemann Uni)

Drug Alias NameBRCA1 modulator (Allegheny)breast cancer susceptibility gene therapeutic (Allegheny)breast cancer susceptibility gene therapeutic (MCP Hahnemann Uni)

ClassificationBiologics

Mechanisms of ActionBreast cancer type 1 susceptibility protein modulators

TargetsBreast cancer type 1 susceptibility protein

Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMCP Hahnemann University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMCP Hahnemann University

Active IndicationsN/A

Inactive IndicationsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A